Along with nutritional support, airway clearance, and now CFTR modulator therapy, the aggressive treatment of cystic fibrosis pulmonary exacerbations – often involving home IV antibiotics – remains a mainstay of CF care. Managing these episodes is crucial to a patient’s success and long-term health. An emerging trend will be the impact of wide-spread adoption of CFTR Modulators on the frequency of these events.
Overview and Pathophysiology of Cystic Fibrosis
Current Treatment Options, both oral, infusion, nutrition, etc.
Utilization of treatment in relation to home infusion and challenges faced by CF patients and CF centers in managing home IV therapy
New and Emerging Treatments for the Cystic Fibrosis patient including the use of CFTR modulator therapy